Age Range
16 - 80
Trial Purpose
Inhloso yalesi simiso ukuhlola ukusebenza kwe-tulisokibart kubahlanganyeli abane-ulcerative colitis emaphakathi kuya eqinile. Imibono eyinhloko ye-Study 1 iwukuthi okungenani ileveli yomthamo we-tulisokibart engu-1 iphakeme kune-Placebo ngenani labahlanganyeli abazuza ukuthethelelwa ngokomtholampilo ngokwe-Modified Mayo Score Evikini le-12, nokuthi okungenani ileveli yomthamo we-tulisokibart ongu-1 ingaphezu kwe-Placebo ngenani labahlanganyeli ngokuya ngeviki le-Modified Mayo 2 lokutholwa komtholampilo. I-hypothesis eyinhloko ye-Study 2 iwukuthi okungenani ileveli yomthamo we-tulisokibart engu-1 iphakeme kune-Placebo ngenani labahlanganyeli abazuza ukuthethelelwa ngokomtholampilo ngokuvumelana ne-Modified Mayo Score Evikini Le-12.
NATIONAL TRIAL REFERENCE NUMBER
I-NCT06052059
EU CT Number
2024-518603-22
When speaking to your doctor or clinical trial representative, please have the trial reference number available.
About The Study
Trial Phase
Trial start and end dates
- Actual study start date Okthoba 25, 2023
- Estimated primary completion date Novemba 21, 2026
- Estimated study completion date Disemba 17, 2029
Trial locations
Sorry, there are no locations found.